NIVOLUMAB EXPERIENCE IN PRETREATED PATIENTS WITH METASTATIC NONSMALL CELL LUNG CANCER (NSCLC) IN THE NORTHERN TERRITORY

被引：0
|
作者：
Yim, Corinne Lau Hing [1 ]
Karanth, Narayan [1 ]
McWiggan, Jemma [1 ]
Perkins, Gary [1 ]
Charakidis, Michail [1 ]
机构：
[1] Royal Darwin Hosp, Casuarina, NT, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
236
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [1] Real World Experience of Nivolumab in Patients with Metastatic Nonsmall Cell Lung Cancer (mNSCLC)
    Ksienski, D.
    Wai, E.
    Lesperance, M.
    Croteau, N.
    Fiorino, L.
    Poonja, Z.
    Geller, G.
    Fenton, D.
    Brooks, E.
    Glick, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S480 - S480
  • [2] Single-center experience with nivolumab in pretreated patients with non-small cell lung cancer (NSCLC).
    Rapoport, Bernardo Leon
    Smit, Teresa
    van Eeden, Ronwyn
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [3] Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer
    Tohi, Makiko
    Irie, Kei
    Mizuno, Tomoyuki
    Okuyoshi, Hiroyuki
    Hirabatake, Masaki
    Ikesue, Hiroaki
    Muroi, Nobuyuki
    Eto, Masaaki
    Fukushima, Shoji
    Tomii, Keisuke
    Hashida, Tohru
    THERAPEUTIC DRUG MONITORING, 2023, 45 (01) : 110 - 116
  • [4] FAILURE OF VINORELBINE TO PRODUCE RESPONSES IN PRETREATED NONSMALL CELL LUNG-CANCER PATIENTS
    PRONZATO, P
    LANDUCCI, M
    VAIRA, F
    VIGANI, A
    BERTELLI, G
    ANTICANCER RESEARCH, 1994, 14 (3B) : 1413 - 1415
  • [5] The relationship between nivolumab pharmacokinetics and cancer cachexia biomarkers in patients with metastatic non-small cell lung cancer (NSCLC)
    Hofman, M.
    Agema, B. C.
    Degens, J.
    Hurkmans, D. P.
    Dumoulin, D. W.
    Schols, A.
    Koolen, S. L.
    Groeneveldt, C.
    Worp, W. V. D.
    Hendriks, L. E.
    Van der Leest, C. H.
    Aerts, J. G.
    Mathijssen, R. H.
    Dingemans, A-M. C.
    Langen, R.
    Bins, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S847 - S847
  • [6] Nivolumab Experience in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC) in Toledo, Spain
    Martinez Moreno, E.
    Irigoyen Medina, A.
    Martinez Barroso, K.
    Borregon Rivilla, M.
    Alvarez Cabellos, R.
    Cardenas, J. D.
    Andrade Santiago, J.
    Burgueno Lorenzo, I.
    Trujillo Alba, B.
    Chacon Lopez-Muniz, J. I.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2430 - S2430
  • [7] NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED NONSMALL CELL LUNG CANCER - CALVARY MATER NEWCASTLE (CMN) EXPERIENCE
    Connolly, Elizabeth
    Mallesara, Girish
    Nordman, Ina I. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 120 - 120
  • [8] FIRST HINTS IN NONSMALL CELL LUNG-CANCER (NSCLC)
    TREAT, J
    GREENBERG, R
    BRATSCHI, J
    GORMAN, G
    MEEHAN, L
    FRIEDLAND, D
    LEUKEMIA, 1994, 8 : S55 - S58
  • [9] Management of Metastatic Nonsmall Cell Lung Cancer in Elderly
    Sheth, Hardik
    Kumar, Prashant
    Limaye, Sewanti
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (03) : 229 - 239
  • [10] Epithelial to mesenchymal transition (EMT) changes in patients with nonsmall cell lung cancer (NSCLC)
    Lu, Wenying
    Chia, Collin
    Larby, Josie
    Haug, Greg
    Hardikar, Ashutosh
    Singhera, Gurpreeet Kaur
    Hackett, Tillie L.
    Robertson, Iain
    Eapen, Mathew Suji
    Sohal, Sukhwinder Singh
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345